Sarepta Therapeutics
The Director of Quantitative & Clinical Pharmacology leads clinical pharmacology and pharmacometrics deliverables across early to late-stage clinical development, focusing on dose selection and predictive PK/PD modeling. This highly visible role drives quantitative pharmacology strategies and serves as the functional lead for global regulatory strategies and health authority engagements. The position requires a PhD with extensive experience in clinical pharmacology and strong regulatory interaction skills.
Headquarters
Cambridge, Massachusetts, United States
Company Size
1001-5000 employees
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sarepta Therapeutics.
9% below the average for this role
Sarepta Therapeutics CEO Doug Ingram will retire after a tumultuous decade
2 weeks ago
Senior Director, Clinical Pharmacology
BridgeBio Pharma
Senior Clinical Pharmacologist
Regeneron Pharmaceuticals
Senior Director/Executive Director, Clinical Pharmacology
8a7882525b6027b0015b692822e001ab
Principal Scientist, Clinical Pharmacology and Pharmacometrics
immunomeinc
Director, Clinical Pharmacology
CSL Behring Australia
Senior Dir, Clinical Pharmacology & Pharmacometrics
Bristol Myers Squibb